Gland Pharma Limited (BOM:543245)

Gland Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 16, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	277,203	262,358	303,932	208,882	537,705	405,432
Market Cap Growth	-11.50%	-13.68%	45.50%	-61.15%	32.63%	-
Enterprise Value	248,206	236,321	286,055	175,977	508,469	390,204
Last Close Price	1681.95	1577.51	1806.28	1244.07	3205.93	2429.88
PE Ratio	35.07	37.56	39.35	26.74	44.38	40.67
PS Ratio	4.78	4.67	5.37	5.76	12.22	11.71
PB Ratio	2.90	2.87	3.48	2.63	7.51	6.87
P/TBV Ratio	3.02	2.98	3.63	2.63	7.53	6.87
P/FCF Ratio	62.58	49.48	50.08	146.03	192.42	107.78
P/OCF Ratio	32.07	28.68	30.49	57.39	68.00	67.02
EV/Sales Ratio	4.28	4.21	5.05	4.86	11.55	11.27
EV/EBITDA Ratio	18.11	19.19	22.06	17.07	33.67	29.97
EV/EBIT Ratio	25.57	27.10	29.45	19.90	36.32	32.42
EV/FCF Ratio	56.03	44.57	47.14	123.03	181.96	103.74
Debt / Equity Ratio	0.03	0.03	0.04	0.00	0.00	0.00
Debt / EBITDA Ratio	0.22	0.25	0.28	0.00	0.00	0.00
Debt / FCF Ratio	0.68	0.59	0.61	0.03	0.02	0.01
Asset Turnover	0.51	0.51	0.58	0.44	0.61	0.65
Inventory Turnover	1.42	1.44	1.40	1.16	1.79	1.56
Quick Ratio	2.79	3.01	2.61	6.58	7.80	7.31
Current Ratio	4.13	4.34	4.04	9.46	10.06	10.00
Return on Equity (ROE)	8.61%	7.82%	9.26%	10.33%	18.55%	20.88%
Return on Assets (ROA)	5.35%	4.98%	6.25%	6.65%	12.21%	14.22%
Return on Invested Capital (ROIC)	9.84%	8.39%	11.67%	16.14%	30.73%	34.27%
Return on Capital Employed (ROCE)	9.60%	9.00%	10.50%	11.00%	19.30%	20.10%
Earnings Yield	2.85%	2.66%	2.54%	3.74%	2.25%	2.46%
FCF Yield	1.60%	2.02%	2.00%	0.69%	0.52%	0.93%
Dividend Yield	1.06%	1.14%	1.11%	-	-	-
Payout Ratio	37.52%	47.17%	-	-	-	-
Buyback Yield / Dilution	0.01%	-0.01%	-0.03%	-0.09%	-3.96%	-2.15%
Total Shareholder Return	1.06%	1.13%	1.07%	-0.09%	-3.96%	-2.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.